Clincosm LogoSign in Get a demo

Hematological Malignancy

Showing 1 - 25 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Hematological Malignancy Trial in Fairfax (Locus Health iPhone App)

Not yet recruiting
  • Solid Tumor
  • Hematological Malignancy
  • Locus Health iPhone App
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Oct 24, 2023

Hematological Malignancy Trial (Thymoglobulin Injectable Product)

Not yet recruiting
  • Hematological Malignancy
  • Thymoglobulin Injectable Product
  • (no location specified)
Sep 27, 2023

Bone Marrow Disease, Hematological Malignancy Trial in Kayseri (Musictherapy)

Active, not recruiting
  • Bone Marrow Disease
  • Hematological Malignancy
  • Musictherapy
  • Kayseri, Turkey
    Kayseri City Hospital
Jun 8, 2023

Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)

Not yet recruiting
  • Hematological Malignancy
  • Solid Tumor
  • (no location specified)
Apr 24, 2023

Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)

Recruiting
  • Hematological Malignancy
  • Cancer-Related Anemia
  • Shengxuening Tablet
  • Ferrous succinate
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Mar 13, 2023

Participants Previously Treated With Century Therapeutics

Not yet recruiting
  • Hematological Malignancy
  • Solid Tumor Malignancy
  • No Intervention
  • (no location specified)
Mar 3, 2023

Advanced Malignancies, Solid Tumor, Hematological Malignancy Trial in Canton, Gettysburg, West Valley City (Pelabresib)

Recruiting
  • Advanced Malignancies
  • +2 more
  • Canton, Ohio
  • +6 more
Jan 30, 2023

Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)

Recruiting
  • Solid Tumor
  • Hematological Malignancy
  • East Melbourne, Victoria, Australia
  • +4 more
Jan 11, 2023

Hematological Malignancy, COVID-19 Trial in Beijing (Anti-COVID-19 Antibody SA55 for Injection)

Recruiting
  • Hematological Malignancy
  • COVID-19
  • Anti-COVID-19 Antibody SA55 for Injection
  • Beijing, Beijing, China
    Beijing Boren Hospital
Jan 9, 2023

Hematological Malignancy Trial in Houston (Fludarabine Phosphate, Cyclophosphamide, CAR.5/IL15-transduced CB-NK cells)

Not yet recruiting
  • Hematological Malignancy
  • Fludarabine Phosphate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

The Optimization of Haploidentical Hematopoietic Stem Cell

Not yet recruiting
  • Hematological Malignancy
  • ATG
  • Post-transplantation cyclophosphamide
  • Beijing, Beijing, China
    People's Hospital of Peking University
Nov 28, 2022

Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)

Recruiting
  • Hematological Malignancy
  • Multiple Myeloma
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Oct 4, 2022

Hematological Malignancy, Neutropenia Trial in Morgantown (Eravacycline)

Not yet recruiting
  • Hematological Malignancy
  • Neutropenia
  • Morgantown, West Virginia
    Aaron Cumpston
Sep 12, 2022

Following Treatment With Fate Therapeutics' Engineered Cellular

Terminated
  • Hematological Malignancy
  • Genetically engineered NK cells
  • Phoenix, Arizona
  • +4 more
Aug 24, 2022

Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Hematological Malignancy
  • Ningbo, Zhejiang, China
    The Affiliated People's Hospital of Ningbo University.
Aug 18, 2022

Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724

Terminated
Has Results
  • Non-Hodgkin's B-cell Lymphoma
  • +5 more
  • MT-3724 Phase 1
  • MT-3724 Phase 2
  • Tucson, Arizona
  • +40 more
Jul 18, 2022

Hematological Malignancy, Lymphoma Trial in Canton (SG2501)

Recruiting
  • Hematological Malignancy
  • Lymphoma
  • Canton, Ohio
    Gabrail Cancer Center Research, LLC
Aug 3, 2022

DxFLEX 10C Clinical Study

Enrolling by invitation
  • Hematological Malignancy
  • DxFLEX 10C
  • Aliso Viejo, California
  • +5 more
Jul 19, 2022

GVHD, Chronic, Hematological Malignancy Trial in Copenhagen (Lee Symptom Scala)

Active, not recruiting
  • GVHD, Chronic
  • Hematological Malignancy
  • Lee Symptom Scala
  • Copenhagen, Denmark
    Rigshospitalet
Jul 14, 2022

Use of nMoABs for the Treatment of COVID-19 in Patients With HM.

Completed
  • Covid19
  • Hematological Malignancy
    • Bari, Italy
    • +13 more
    Jun 21, 2022

    Hematological Malignancy Trial in Roskilde (Taste-test, Standard care)

    Enrolling by invitation
    • Hematological Malignancy
    • Taste-test
    • Standard care
    • Roskilde, Denmark
      Department of Hematology
    May 5, 2022

    Solid Tumor, Hematological Malignancy Trial in Beijing (Metoprolol, metoprolol, infliximab, etanercept, tocilizumab and/or other

    Recruiting
    • Solid Tumor
    • Hematological Malignancy
    • Metoprolol
    • metoprolol, infliximab, etanercept, tocilizumab and/or other agents
    • Beijing, Beijing, China
      Biotherapeutic Department of Chinese PLA General Hospital
    Apr 8, 2022

    CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)

    Not yet recruiting
    • CXCR4
    • +2 more
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Feb 15, 2022

    Solid Tumor, Hematological Malignancy Trial in Bayonne, Bordeaux, Pau (Newly obtained biopsy and Blood samples collection)

    Recruiting
    • Solid Tumor
    • Hematological Malignancy
    • Newly obtained biopsy and Blood samples collection
    • Bayonne, France
    • +5 more
    Feb 1, 2022

    Membrane Target Detection for Leukemia Treatment

    Recruiting
    • Hematological Malignancy
    • Study sample collection
    • Columbia, Missouri
      University of Missouri
    Dec 29, 2021